ReviewArchives of toxicology2025
Developmental neurotoxicity of organophosphate flame retardants (OPFRs): risks to human health and ecosystems.
Review in Archives of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Exposure to second-generation flame retardants and risk of metabolic diseases: a systematic review and meta-analysis.Archives of toxicology · 2026Pooled it
- Life-Cycle Diphenyl Phosphate (DPhP) Exposure Reveals Sex-Differential Functional Alterations in the Zebrafish Gut Microbiota.Biology · 2026Article
- Evaluation of Migration, Bioaccessibility, and Dietary Risk of Organophosphate Flame Retardants in Polypropylene Packaging Using a Packaging-Food-Digestion Simulation System.Foods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Organophosphate flame retardants (OPFRs), widely used as primary alternatives to banned brominated flame retardants, have been extensively applied across various industries worldwide. In recent years, OPFRs have increasingly emerged as significant environmental pollutants and have been shown to possess potential developmental neurotoxicity. This review systematically synthesizes current research on their environmental distribution, bioaccumulation, and neurodevelopmental effects. Studies indicate OPFRs are widely detected in air, water, soil, and organisms, demonstrating high environmental persistence and mobility. Humans are exposed through inhalation, ingestion, and dermal absorption, with infants and young children at higher risk due to frequent hand-to-mouth behavior and prolonged indoor exposure. Epidemiological studies suggest that prenatal exposure to OPFRs may be associated with low birth weight, behavioral abnormalities, and cognitive deficits, with evidence of sex-specific susceptibility. Experimental studies using model organisms, such as zebrafish and rodents, have further elucidated the potential mechanisms underlying OPFR-induced developmental neurotoxicity. Chemicals such as TDCPP, TPhP, and TCEP have been found to disrupt neural cell proliferation and differentiation, dysregulate gene expression, induce neuroinflammation, increase oxidative stress, and impair endocrine homeostasis. Despite significant progress in understanding the toxicity of OPFRs, critical scientific challenges remain unresolved. For example, the long-term effects of low-dose OPFR exposure on the nervous system are not yet fully understood. Furthermore, there is a lack of systematic analysis regarding the combined effects of multiple pollutants. Therefore, a deeper understanding of the toxicological mechanisms of OPFRs is essential to provide a stronger scientific foundation for the formulation of evidence-based environmental and public health policies.
Indexed as
Identifiers
40944736What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.